We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Methotrexate in rheumatoid arthritis: a prospective study in Israeli patients with immunogenetic correlations.
- Authors
Tishler, M; Caspi, D; Rosenbach, T O; Fishel, B; Wigler, I; Segal, R; Gazit, E; Yaron, M
- Abstract
In a prospective open study 44 Israeli patients with rheumatoid arthritis were treated with weekly low dose methotrexate (MTX) for up to 36 months. Nine patients withdrew from the study: six because of side effects and three due to inefficacy. One patient died of septicaemia following septic arthritis. Significant improvement, graded by Ritchie articular index, grip strength, physician's global assessment, erythrocyte sedimentation rate (ESR), and platelet counts, was noticed in response to treatment. Seronegative patients had a better clinical response. Transient gastrointestinal symptoms were common and correlated with increases of serum aspartate transaminase (AST). HLA-DR1 and DR7 were significantly associated with increased serum AST concentrations.
- Publication
Annals of the rheumatic diseases, 1988, Vol 47, Issue 8, p654
- ISSN
0003-4967
- Publication type
Journal Article
- DOI
10.1136/ard.47.8.654